For more information on other emerging options, enroll in OMAs course on Investigational Anti-Obesity Drugs in the Pipeline
These side effects are usually mild to moderate and may decrease or go away entirely after a few days or weeks of treatment
Commonly Reported Side Effects Nausea Diarrhea or constipation Vomiting Stomach discomfort Loss of appetite Severe Adverse Events Patients across the U.S
These are closely monitored by physicians and health organizations
Samuel VT, Liu ZX, Wang A, Beddow SA, Geisler JG, Kahn M, Zhang XM, Monia BP, Bhanot S, Shulman GI (2007) Inhibition of protein kinase Cepsilon prevents hepatic insulin resistance in nonalcoholic fatty liver disease